Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept.
Ioannou Y, Romay-Penabad Z, Pericleous C, Giles I, Papalardo E, Vargas G, Shilagard T, Latchman DS, Isenberg DA, Rahman A, Pierangeli S. Ioannou Y, et al. Among authors: pericleous c. J Thromb Haemost. 2009 May;7(5):833-42. doi: 10.1111/j.1538-7836.2009.03316.x. Epub 2009 Feb 12. J Thromb Haemost. 2009. PMID: 19220729 Free article.
Thrombin binding predicts the effects of sequence changes in a human monoclonal antiphospholipid antibody on its in vivo biologic actions.
Giles I, Pericleous C, Liu X, Ehsanullah J, Clarke L, Brogan P, Newton-West M, Swerlick R, Lambrianides A, Chen P, Latchman D, Isenberg D, Pierangeli S, Rahman A. Giles I, et al. Among authors: pericleous c. J Immunol. 2009 Apr 15;182(8):4836-43. doi: 10.4049/jimmunol.0804241. J Immunol. 2009. PMID: 19342662 Free article.
Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways.
Lambrianides A, Carroll CJ, Pierangeli SS, Pericleous C, Branch W, Rice J, Latchman DS, Townsend P, Isenberg DA, Rahman A, Giles IP. Lambrianides A, et al. Among authors: pericleous c. J Immunol. 2010 Jun 15;184(12):6622-8. doi: 10.4049/jimmunol.0902765. Epub 2010 May 17. J Immunol. 2010. PMID: 20483743 Free PMC article.
New therapeutic targets for the antiphospholipid syndrome.
Pericleous C, Ioannou Y. Pericleous C, et al. Expert Opin Ther Targets. 2010 Dec;14(12):1291-9. doi: 10.1517/14728222.2010.524207. Epub 2010 Sep 28. Expert Opin Ther Targets. 2010. PMID: 20874375 Review.
Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.
Ioannou Y, Zhang JY, Qi M, Gao L, Qi JC, Yu DM, Lau H, Sturgess AD, Vlachoyiannopoulos PG, Moutsopoulos HM, Rahman A, Pericleous C, Atsumi T, Koike T, Heritier S, Giannakopoulos B, Krilis SA. Ioannou Y, et al. Among authors: pericleous c. Arthritis Rheum. 2011 Sep;63(9):2774-82. doi: 10.1002/art.30383. Arthritis Rheum. 2011. PMID: 21618459 Free PMC article.
52 results